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Summary 
The aryl hydrocarbon receptor (AHR) and the AHR nuclear translocator (ARNT) comprise a hetero-
dimeric basic-helix-loop-helix-Per-ARNT-Sim (bHLH-PAS) domain-containing transcription factor 
with central functions in development and cellular homeostasis. AHR is activated by xenobiotics, 
notably dioxin, as well as by exogenous and endogenous metabolites. Modulation of AHR activity holds 
promise for the treatment of diseases featuring altered cellular homeostasis, such as cancer or 
autoimmune disorders. Here, we present the crystal structure of a heterodimeric AHR:ARNT complex 
containing the PAS A and bHLH domain bound to its target DNA. The structure provides insights into 
the DNA binding mode of AHR and elucidates how stable dimerization of AHR:ARNT is achieved 
through sophisticated domain interplay via three specific interfaces. Using mutational analyses, we 
prove the relevance of the observed interfaces for AHR-mediated gene activation. Thus, our work 
establishes the structural basis of AHR assembly and DNA interaction and provides a template for 
targeted drug design. 
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Introduction 
 The aryl hydrocarbon receptor (AHR) and the AHR nuclear translocator (ARNT) belong to the 
family of basic helix-loop-helix-PER-ARNT-SIM (bHLH-PAS) domain containing transcription 
factors. Members of this family respond to various external stimuli in order to regulate diverse 
biological processes, including cellular differentiation (Gasiewicz et al., 2014), malignant 
transformation (Murray et al., 2014), immune responses (Stockinger et al., 2014) and circadian 
rhythmicity (Anderson et al., 2013). Proteins of the ARNT subfamily were grouped into the class II 
bHLH-PAS domain containing transcription factors, which localize to the nucleus. They can hetero-
dimerize with members of the class I subfamily of bHLH-PAS proteins, such as AHR, the hypoxia 
inducible factors (HIF-1α/HIF-2α), the neuronal PAS domain proteins (NPAS) and single-minded 
proteins (SIM1/SIM2), in order to regulate the transcriptional response to xenobiotics, hypoxia and 
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neurogenesis, respectively (Denison et al., 2003; Kewley et al., 2004). In contrast to ARNT, AHR is a 
cytosolic signal sensor, which is guided into the nucleus upon binding of planar aromatic hydrocarbons. 
The best known high-affinity ligand for AHR is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 
mediating its toxicity via activation of AHR (Poland et al., 1976; Perdew, 1992; Greenlee et al., 1979). 
Endogenous ligands of AHR include tryptophan-derived metabolites (Opitz et al., 2011; Denison et al., 
2003; Veldhoen et al., 2009) and several dietary indoles, which are thought to modulate immune 
responses (Hubbard et al., 2015; Kiss et al., 2011; Li et al., 2011). More recently, bacterial metabolites 
from Pseudomonas and Mycobacterium strains were shown to bind and activate AHR to sense bacterial 
virulence and both activate antibacterial responses (Moura-Alves et al., 2014) and control sepsis 
(Bessede et al., 2014). In addition, AHR signaling is intricately involved in fine-tuning distinct immune 
responses, particularly at environmental interfaces where endogenous and exogenous AHR ligands 
accumulate (Zelante et al., 2013; Wincent et al., 2012; Kadow et al., 2011; Schiering et al., 2017). For 
instance, AHR activity is a key determinant of T helper (Th) cell differentiation (Gagliani et al., 2015; 
Di Meglio et al., 2014). Strikingly, ligands with differential AHR agonist activity may have opposing 
effects on Th cell differentiation, illustrating the delicate regulation of this transcription factor at the 
ligand-binding level (Quintana et al., 2008). Increased levels of AHR and its target genes, as well as 
constitutive localization of AHR in the nucleus, were also found in several aggressive tumors such as 
glioblastoma, skin tumors or non-small cell lung cancer (Opitz et al., 2011; Poland et al., 1982; Su et 
al., 2013; Liu et al., 2013). These observations render the AHR:ARNT complex an interesting target 
for the development of drugs targeting cancer (Opitz et al., 2011), and autoimmune conditions such as 
multiple sclerosis (Quintana et al., 2008; Veldhoen et al., 2008; Mascanfroni et al., 2015, Quintana et 
al., 2010). 
 AHR and ARNT are composed of an amino (N-)terminal bHLH domain required for DNA 
binding, followed by two PER-ARNT-SIM (PAS) domains (A and B) and a carboxy (C-)terminal trans-
activation domain (TAD) (Fukunaga et al., 1995; Crews et al., 1999) (Fig. 1A). The bHLH domains of 
AHR dimerize to form a four-helical bundle (Pongratz et al., 1998), which can bind to distinct DNA 
motifs leading to transcriptional activation of target genes (Reyes et al., 1992). The dioxin response 
element (DRE, 5’- NGCGTG -3’, in which N stands for any nucleotide) was identified as the minimal 
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DNA sequence recognized by the bHLH domains of the AHR:ARNT complex (Yao et al., 1992; 
Swanson et al., 1995). It can be subdivided into a 5' part (NGC) recognized by AHR, and a 3' part 
(GTG) recognized by ARNT.  
 Biochemical and mutagenesis studies indicate that the PAS A domains of AHR and ARNT also 
dimerize with each other, thereby controlling dimerization specificity, enhancing complex stability and 
strengthening DNA binding (Pongratz et al., 1998; Erbel et al., 2003; Lindebro et al., 1995; Chapman-
Smith et al., 2004). Crystal structures of the hetero-dimeric CLOCK:BMAL complex (Huang et al., 
2012), a PAS A domain dimer of AHR (Wu et al., 2013), the hetero-dimeric HIF:ARNT complex (Wu 
et al., 2015) and, most recently, the NPAS1:ARNT and NPAS3:ARNT heterodimers (Wu et al., 2016) 
provided molecular insights into the dimerization and DNA binding modes of bHLH-PAS domain 
proteins. The ‘connector helix’ of the PAS A domain was shown to play a major role in its dimerization. 
The PAS B domains of AHR and ARNT differ from the PAS A domains by a three loop insertion, as 
initially found in the crystal structure of the tandem PAS domain containing PERIOD protein (Yildiz 
et al., 2005). They have also been suggested to contribute to hetero-dimerization (Erbel et al., 2003; 
Huang et al., 2012; Wu et al., 2015). In AHR, the PAS B domain constitutes the ligand binding domain 
(Poland et al., 1976; Poland et al., 1982; Burbach et al., 1992). Interestingly, an AHR construct lacking 
the PAS B domain forms a constitutively active dimer in mice (Andersson et al., 2002), which suggests 
that ligand binding is only required for AHR translocation into the nucleus, and not for hetero-
dimerization and trans-activation. 
Here, we present the crystal structure of an AHR:ARNT transcription factor complex 
containing the bHLH and PAS A domains bound to a 12mer double strand (ds) DNA. The structure 
provides the framework to understand AHR-based gene activation and serves as a template for the 
design of AHR targeting drugs.  
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Results 
Structure determination of an AHR:ARNT complex bound to DNA  
To obtain structural insights into AHR-mediated gene activation, we sought to establish a 
purification protocol for the AHR:ARNT complex. Since all attempts to produce a soluble AHR 
construct including the PAS B domain failed, we co-expressed truncated human AHR and mouse 
ARNT constructs without the PAS B and transactivation domain (TAD) (Fig. 1A, referred to as AHR’ 
and ARNT’ from hereon). Deleting a predicted internal loop in the PAS A domain of ARNT (Δ274-
301) and mutating a reactive cysteine (C256S, in the ARNT’Δ construct) increased protein yields and 
allowed the successful purification of the complex (Fig. 1B, Methods).  
Assembly of the purified complex was analyzed by analytical gel filtration, combined with a 
right-angle laser scattering (RALS) analysis. In these experiments, a stable heterodimeric complex of 
about 60 kDa was observed, comprising one molecule of AHR’ (26 kDa) and ARNT’Δ (29 kDa) each 
(Fig. 1C). Addition of a 12mer dsDNA oligomer containing the DRE motif in its center slightly 
decreased the retention time in gel filtration analysis but increased the OD260/OD280 ratio of the peak 
fraction, indicating stable DNA binding. In contrast, purified ARNT protein was monomeric and formed 
homo-dimers only upon binding to a DNA sequence containing a central palindromic 5’-CAC-GTG-3’ 
motif corresponding to the ARNT binding sequence (Sogawa et al., 1995) (Fig. S1). 
To quantitate DNA binding of the AHR’:ARNT’ complex, the affinities towards dsDNA of 
various lengths, containing a central DRE motif, were determined by isothermal titration calorimetry 
(ITC) experiments. dsDNA oligomers of 16, 14 and 12 nucleotides in length bound the AHR:ARNT 
complex with an affinity of approximately 100 nM (Figs. 1D, E), indicating that bases flanking the DRE 
element beyond the 12mer sequence do not influence the binding affinity. Further shortening of the 
dsDNA to a 10mer sequence led to an 8-fold reduction in the binding affinity (KD = 790 nM). Thus, 
although not directly involved in DNA interactions (see below), residues in the immediate vicinity of 
the DRE motif may influence DNA binding, for example by altering DNA stability or structure. 
To explore the structural basis of AHR-mediated gene transcription, we crystallized the 
AHR’:ARNT’ complex bound to the 12mer dsDNA. Crystals of this complex diffracted to 3.3 Å 
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resolution (Table 1). Experimental phases were calculated using erbium ions as anomalous scatterers 
resulting in a clearly interpretable electron density map. The final Rwork/Rfree of the model was 
29.2%/33.3%.  
The asymmetric unit contained two hetero-dimeric AHR‘:ARNT’ complexes (complex 1 and 
2), each bound to a dsDNA (Fig. S2A). These two complexes showed a similar architecture and 
orientation of their domains. They could be superimposed with a root mean square deviation (rmsd) of 
0.9 Å for 252 Cα atoms (Fig. S2B). Due to missing crystal contacts, the PAS A domains of AHR’ and 
ARNT’ in complex 2 were not well resolved in electron density and could be modelled only 
incompletely (see Star Methods). Therefore, the following discussion refers to complex 1. 
 
DNA binding of AHR’:ARNT’ 
The AHR’:ARNT’ complex has an intertwined architecture, with all four domains 
participating in the assembly (Fig. 2A). The bHLH domains show a prototypical structure comprising 
two helices and a flexible connector. Similar to other bHLH domain containing proteins, the DRE motif 
(underlined in the sequence of the 12mer oligomer 1GGTTGCGTGACC12) is bound in between the two 
N-terminal α1-helices via an interface of 890 Å2 (Fig. 2B, C, S3, S4). Similar to the Hif-2:ARNT 
complex (Wu et al., 2015), His94 and Arg102 of ARNT interact with the terminal guanine base in the 
DRE motif of one DNA strand whereas Glu98 binds to the adenine and cytosine base of the 
complementary strand. AHR interacts via Ser36, His39 and Arg40 with the other half-site of the DRE 
motif. His39 contacts the phosphate backbone of the thymine base whereas Ser36 and Arg40 form 
hydrogen bonds to the cytosine and guanine of the complementary DNA strand. In agreement with our 
structure, His39 and Arg40 in human AHR and His79, Asp83, Arg86 and Arg87 in human ARNT 
(corresponding to His94, Glu98, Arg102, Arg103 in mouse ARNT) were previously shown to be crucial 
for DRE binding (Reisz-Porszasz et al., 1994; Dolwick et al., 1993; Bacsi et al., 1995; Dong et al., 
1996). Overall, the DNA binding mode in bHLH-PAS transcription factors is related although the 
detailed interactions differ allowing specific sequence recognition (Fig. 2C). 
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Assembly of AHR’:ARNT’ 
Dimerization of AHR' and ARNT’ is mediated by an intricate domain interplay, involving 
interaction interfaces in both the bHLH and PAS A domains (Fig. 3A-F). The bHLH domains interact 
with each other via two hydrophobic interaction sites covering 980 Å2 involving helices 1 and 2 
(from here on referred to as interface 1 according to (Wu et al., 2016)). For example, Ile109 and Leu112 
in 1 of ARNT interacts with Val74 and Leu70 in 2 of AHR (Fig. 3A, Interface 1a). A second contact 
site is provided by a hydrophobic surface between 1 of AHR and 2 of ARNT, in which Leu47, Leu50 
and Leu53 of AHR interact with Leu132, Val136 and Met139 of ARNT (Fig. 3B, Interface 1b). 
 As previously described (Wu et al., 2013; Wu et al., 2015; Wu et al., 2016), the PAS A domains 
of AHR and ARNT have a canonical PAS domain fold containing a five stranded antiparallel β-sheet 
flanked by four helices at one side. They form an extensive dimerization interface of 1030 Å2 to which 
we refer as interface 2. At the N-terminus of the PAS A domains, the helical connectors (A' display 
a number of mainly hydrophobic contacts with each other and with residues in the opposing PAS A 
domain. For example, hydrophobic interactions are mediated by Leu118, Leu119 and L122 in A' of 
AHR with Leu164 and Ile168 in A' of ARNT, whereas Asp114 in AHR forms a salt bridge to Lys165 
in ARNT (Fig. 3C, Interface 2a). Furthermore, Phe158, Leu159, Leu167, Ile168 and Ala172 N-
terminally of ARNT A’ form a hydrophobic interface with Tyr137, Val126, Phe266, Ile268 in the 
PAS A domain of AHR (Fig. 3D, Interface 2b). Vice versa, Phe117, Leu118, Ala121 and Leu122 in 
A' of AHR interact with Leu176, Ile340, Thr309 and Arg260 in the PAS A domain of ARNT (Fig. 
3E, Interface 2c).  
A third, mostly intramolecular interface of 960 Å2 is formed between the bHLH and the PAS 
A domain of AHR. Phe56, Val60, Leu72, Ala79, Phe82 in the bHLH domain form a hydrophobic 
network to Phe136, Ser151, Ile154, and Leu246 in the PAS A domain. Furthermore, Pro55, Phe56, 
Tyr76, Ala79 and Phe83 in the AHR bHLH domain interact with Pro156, Ser157, Phe158, Leu159 in 
the N-terminal region of the helical connector and with Glu163 in the helical connector of ARNT (Fig. 
3F, Interface 3). 
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The identified interfaces explain previously described mutations affecting assembly of AHR 
and ARNT. Based on the crystal structure of the PAS A domain dimer of AHR, Wu and co-workers 
found that single mutations of Glu112, Phe115, Leu116, Ala119, Leu120, Val124, Phe260 and Ile262 
in mouse AHR (corresponding to Glu114, Phe117, Leu118, Ala121, Leu122, Val126, Phe266, Ile268 
in human AHR) disrupt formation of the AHR:ARNT complex, leading to reduced activation of a 
reporter gene (Wu et al., 2013). These residues directly participate (Glu114, Leu118, Ala121, Leu122, 
Phe266, Ile268) or are close to (Phe117, Val126) interface 2. In addition, mutations of interface 2 
residues Leu167, Ile168, Ala171 in mouse ARNT were shown to disrupt dimerization (Wu et al., 2013). 
Two further studies found that mutations of Glu112 in mouse AHR (corresponding to Glu114 in human 
AHR) and of Glu163, Ala339 and Gly341 in mouse ARNT interfere with dimerization, in agreement 
with their direct involvement in interface 2 or 3 (Numayama-Tsuruta et al., 1997; Hao et al., 2011). 
To further evaluate the AHR:ARNT domain interfaces, we used a reporter gene assay, in which GFP 
expression was driven under the control of an DRE-dependent promotor. Co-expression of full length 
ARNT and a constitutively active AHR (AHR.cA) with an internal deletion of the PAS B domain 
(Andersson et al., 2002) yielded robust, ligand-independent activation of the GFP reporter gene (Fig. 
3G). Subsequently, we tested the effects of replacing single residues in AHR.cA and ARNT with 
negatively charged aspartate on gene transcription (Fig. 3G). In agreement with the structural data, 
mutations of the DNA binding residues Arg40 in AHR.cA and Arg102 in ARNT decreased reporter 
gene activation. Also mutations in interface 1 (L50D, V74D in AHR, L112D, M139D in ARNT), 
interface 2 (L118D and L122D in AHR.cA) and interface 3 (A79D, F82D, F136D, I154D in AHR.cA) 
interfered with gene activation. In contrast, the L164D mutation in ARNT in interface 2 did not have 
an effect. Leu164 locates to the periphery of interface 2 and its replacement by aspartate apparently 
does not interfere with a functional AHR.cA:ARNT complex. Overall, these data are in agreement with 
crucial roles of the observed interfaces in AHR-dependent gene activation. 
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Discussion 
bHLH-PAS transcription factors are central regulators of cellular homeostasis. Given their 
crucial functions in health and disease, it is astonishing that structural data reporting their DNA binding 
properties and assembly modes only recently became available. The CLOCK-BMAL structure revealed 
an asymmetric heterodimer, in which both the bHLH, PAS A and PAS B domains contributed to 
dimerization (Huang et al., 2012). Despite the close relationship, the overall topology is clearly different 
compared to our structure of the AHR:ARNT complex (Fig. 4A). More recently, the structure of HIF-
1 and 2-ARNT heterodimers bound to DNA revealed an alternate conformation of bHLH-PAS 
transcription factors in which the two PAS A domains were rotated with respect to the bHLH domain 
(Wu et al., 2015). Consequently, it was unclear which conformation is adopted by AHR:ARNT dimers, 
and modeling studies yielded conflicting results (Corrada et al., 2016). Our current structural analysis 
indicates that AHR:ARNT shows a similar conformation compared to HIF-2:ARNT bound to DNA 
(Fig. 4B). Very recently, the structures of NPAS1- and NPAS2:ARNT bound to DNA were also 
demonstrated to have a similar overall topology as the AHR:ARNT dimers (Fig. 4C) (Wu et al., 2016). 
The structural similarities of the AHR:ARNT, HIF-2α:ARNT and NPAS:ARNT complexes may be 
related to the common ARNT subunit and its absence in the CLOCK:BMAL complex. Interestingly, 
when comparing the two PAS A domains in our structure to those of the AHR PAS A domain dimer 
(Wu et al., 2013), an almost 70° rotation of the second subunit was observed (Fig. 4D), pointing to a 
non-physiological domain assembly of the PAS A domain dimer. 
DNA binding of AHR:ARNT is mediated by the bHLH domains which interact via positively 
charged residues with the DNA. Similar to the HIF-2:ARNT complex, ARNT in the AHR complex 
recognizes its target sequence GTG via the conserved His94, Glu98 and Arg102. Specificity of DNA 
recognition of the AHR:ARNT complex is mediated by Ser36, His39 and Arg40 of AHR which contact 
the first three bases of the DRE motif. In contrast, HIF-2 uses Ala23 and Arg27 to recognize a TAC 
sequence. Interestingly, in HIF-, also the PAS A domain participates in DNA binding via a loop 
structure (Wu et al., 2015). In contrast to HIF-2, we did not observe such a contact in the AHR PAS 
A domain. The corresponding loop is 8 amino acids shorter in AHR and CLOCK compared to HIF-2 
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and may therefore not reach the DNA, whereas it has a similar size as HIF-2 in NPAS proteins (Fig. 
1D, S3).  
In the published bHLH-PAS structures, the PAS B domain is intimately involved in 
dimerization. However, we found that AHR:ARNT can stably dimerize without the PAS B domain. 
Furthermore, despite the absence of the PAS B domain, an active, DNA binding conformation was 
adopted. These observations point to a regulatory function of the PAS B domain in gene activation and 
are in agreement with previous deletion analysis (Andersson et al., 2002). Thus, ligand binding to the 
PAS B of AHR domain may release auto-inhibitory constraints, thereby allowing nuclear localization 
of AHR and dimerization with ARNT via the described interfaces. Whether PAS B domain interactions 
in the AHR:ARNT complex have a functional relevance needs to be further examined. 
bHLH-PAS domain proteins, and in particular the AHR transcription factor, comprise 
interesting targets for the development of therapeutic agents (Scheuermann et al., 2013). For example, 
it was shown that AHR activation by the endogenous ligand kynurenine promotes the development of 
glioblastoma (Opitz et al., 2011), thus an AHR inhibitor is expected to suppress tumor growth and 
metastasis and enhance anti-tumor immunity. Our structure may guide rational drug design approaches: 
for example, inhibitors targeting the DNA binding site of the bHLH domains may specifically interfere 
with transcription of the AHR:ARNT complex without affecting related bHLH PAS domain 
transcription factor complexes, while the assembly interfaces 1-3 may also be targeted. Sequence 
comparisons indicate that residues in the assembly interfaces are highly conserved within the class II 
bHLH transcription factor family, but deviate to a larger extent in the class I family (Fig. 4E, F, S3, S4). 
For example, all ARNT residues referred to in the text are completely invariant in the ARNT family, 
whereas AHR residues Leu47, Leu53, Val74 in interface 1, Val126, Phe136, Ile154, Leu246, Phe266, 
Ile268 in interface 2 and Val60, Ala79, Phe82, Phe83 in interface 3 are only partially conserved in class 
I transcription factors. Furthermore, published biochemical data indicate differential importance of 
interface residues for the assembly. For example, mutations F100D and L160E in NPAS1 were reported 
not to disturb assembly with ARNT (Wu et al., 2016), whereas mutations in corresponding positions in 
AHR (F82D, F136D) interfere with AHR-mediated gene transcription. Thus, even closely related 
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transcription factors complexes, such HIF-2:ARNT, NPAS:ARNT and AHR:ARNT may offer unique 
surfaces in their PAS A and bHLH domains to specifically target assembly and function by small 
molecule inhibitors. Our study also indicates that small molecule inhibitors of the PAS B domain will 
likely not interfere with dimerization, but could alternatively affect the function of the AHR:ARNT 
complex, for example by modifying translocation of AHR into the nucleus. 
Our structural data on AHR:ARNT lay the foundation for understanding AHR-dependent gene 
activation and provide a template for structure-guided drug design. 
Note added in proof: While our manuscript was in review, a related AHR-ARNT structure bound to 
DNA was reported (Seok et al., 2017).  
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Figures: 
 
 
Figure 1: The dimeric AHR’:ARNT’ complex binds with high affinity to DNA 
A) Domain architecture of AHR and ARNT. Numbers at the domain boundaries refer to the amino acids 
of the human proteins. The crystallized constructs are indicated below. B) SDS gel showing the purified 
AHR’:ARNT’ complex. M: marker. C) Analytical gelfiltration analysis coupled to RALS using 150 
µg of the AHR’:ARNT’ complex in the absence (red) and presence (blue) of the 12mer dsDNA. UV 
absorbance is shown in dark colors and refers to the left y-axis, while the absolute molecular mass as 
determined by RALS is shown in light colors and refers to the right y-axis. D) Top: A DNA solution 
containing the 12mer dsDNA with the central DRE motif was titrated to the AHR’:ARNT’ complex 
at 20 °C, and the time-dependent resulting heat changes were monitored by ITC. Bottom: Binding 
isotherms were derived by integration of the heat peaks and fitted to a quadratic binding equation. E) 
Table showing the equilibrium dissociation constants (KD; middle panel) of the 16mer, 14mer, 12mer 
and 10mer ds DNA (left panel) to the AHR’:ARNT’∆ complex determined by ITC measurements. 
Errors represent standard errors of the fit. The substoichiometric binding numbers N may be explained 
by incomplete annealing of the titrated dsDNA oligomers. See also Fig. S1.  
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Figure 2: Structural basis of DNA binding. 
A) Crystal structure of the AHR’:ARNT’ complex bound to DNA (domain colors as in Fig. 1A). 
Distinct interfaces in the AHR:ARNT complex are boxed and shown in higher magnification in Fig 2B 
and 3. The nucleotide sequence of the 12mer dsDNA oligomer is shown at the bottom. N- and C-termini 
are marked. B) Structural details of DNA binding by the AHR’:ARNT’ complex. C) Schematic 
interaction diagram of various bHLH-PAS complexes with DNA. The HIF-2:ARNT and 
CLOCK:BMAL interactions were derived from pdb entry 4ZPK (Wu et al., 2015) and 4H10 (Wang et 
al., 2013), respectively. See also Fig. S2. 
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Figure 3: Structural determinants of oligomerization. 
A-F) Structural details of the indicated interfaces. Selected residues involved in interface formation are 
shown in stick representation. Dotted lines represent hydrophobic or polar contacts. 
G) Probing the effect of AHR:ARNT interface mutations on DRE reporter expression containing 
repeats of the 21bp motif TGAGTTCTCACGCTAGCAGAT in HEK293T cells. Publicly available 
RNAseq data (www.proteinatlas.org) suggested that HEK293T cells express endogenous AHR and 
ARNT at low levels, resulting in low background reporter activity. Overexpression of AHR.cA or 
ARNT alone has limited effects on reporter activity without cotransfection of the second subunit, 
suggesting both are limiting in HEK293T cells. All tested mutants, except L164D, show significantly 
decreased DRE reporter activity relative to cotransfection of non-mutagenized forms. Data represent 
the mean +/- SEM of three biological replicates normalized to the highest intensity result, where within 
each biological replicate each condition was repeated in triplicate. See also Fig. S3 and S4. 
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Figure 4: Structural comparisons to other bHLH transcription factors. 
(A-D) Superposition of the AHR’:ARNT’ DNA complex (colors as in Fig. 2A) with (A) the bHLH-
PAS A domains of the BMAL:CLOCK structure (pdb 4F3L), (B) the bHLH and PAS A domains of the 
HIF-2:ARNT-DNA complex (pdb 4ZPK), (C) the bHLH and PAS A domains of the NPAS3:ARNT-
DNA complex (pdb 5SY7), (D) the dimeric PAS A domain of human AHR (pdb 4M4X). For the latter, 
two AHR domains were superimposed, indicating a 70° rotation of the second AHR versus the ARNT 
PAS A domain. (E,F) The conservation of human class I (Fig. S3) and class II (Fig. S4) bHLH 
transcription factor sequences was plotted onto the four interaction interfaces of the AHR’:ARNT’ 
complex. Shown are two views on the AHR (E) and ARNT (F) molecules. 80% type conserved residues 
in AHR and 100% type conserved residues in ARNT are shown in darker colours, non-conserved 
residues in lighter colours (see legend for the colour scheme of the interfaces). See also Fig. S3 and S4. 
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Data collection  Er3+ data set 
Beamline BESSY II BL 14.1 
Wavelength [Å] 1.476 
Space group P6522 
Cell dimensions  
a, b, c [Å] 91.32, 91.32, 461.91 
α, β, γ [°] 90.00, 90.00, 120.00 
Resolution [Å]ᵃ 50.00 (3.49)- 3.3 
Rmeas [%] 12.6 (63.7) 
I/σ 17.48 (4.5) 
Completeness [%] 99.6 (98.5) 
Redundancy 20.2 (18.6) 
Refinement  
Resolution [Å] 50.00 (3.47) - 3.3 
No. reflections 18,323 (2,352) 
Rwork/Rfree [%]b 29.2/33.3 (31.6/41.5) 
Complexes/ASU 2 
No. protein/DNA atoms/ASU 5,836 
Avg. B-factor [Å2] 106 
No. Er3+ atoms 12 
Avg. B-factor [Å2] 116 
R.m.s. deviations  
 Bond length [Å] 0.005 
 Angles [°] 0.678 
Ramachandran favored [%] 91 
Ramachandran outlier [%] 0.5 
 
Table 1: Data collection and refinement statistics of the Er(III) containing AHR’/ARNT’ 
complex bound to 12mer dsDNA.  
 
a Numbers in parentheses apply to the highest resolution shell.  
b5% of the reflections were excluded from refinement to calculate Rfree. The relatively high R factors 
may be explained by the two flexible PAS A domains of complex 2, which could be modelled only 
incompletely. 
Complexes/ASU – AHR’-ARNT’DNA complexes per asymmetric unit. 
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STAR methods 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to and will be fulfilled 
by the Lead Contact, Oliver Daumke (oliver.daumke@mdc-berlin.de). 
 
METHOD DETAILS 
Protein expression and purification: A codon-optimized cDNA of human (hs) AHR encoding amino 
acid residues 23-273 was commercially synthesized (MWG Eurofins) and cloned into pET32-EK/LIC 
(Novagen). Mouse ARNT (residues 85-345), Δ274-301, C256S was cloned into pET30-EK/LIC 
(Novagen). Both constructs were co-expressed as N-terminal Hexa-His-fusion proteins in BL21 
Rosetta2(DE3) cells, followed by a PreScission cleavage site. Bacteria were grown to an OD600 of 0.5 
in TB medium when protein expression was induced with 200 µM Isopropyl-β-D-thiogalactopyranosid 
(IPTG), followed by overnight expression at 18 °C. Cells were resuspended in ice-cold lysis buffer (20 
mM HEPES/NaOH pH 8.0, 200 mM NaCl, 100 µM Pefabloc SC (Roth), 1 µM DNAse (Roth), 5 mM 
β-mercaptoethanol (βME) and lyzed using a microfluidizer (Microfluidics, Newton, USA). After 
centrifugation at 100,000 x g for 45 min at 4 °C, the supernatant was applied to a Ni-nitroloacetic acid 
(NTA) column pre-equilibrated with equilibration buffer (20 mM HEPES/NaOH pH 8.0, 200 mM 
NaCl, 5 mM βME), and afterwards extensively washed with the same buffer. The protein was eluted 
using equilibration buffer containing 200 mM imidazole. PreScission protease was added in a 1:200 
ratio (w/w) to cleave the N-terminal His-tag of AHR and ARNT, while dialyzing overnight against 20 
mM HEPES/NaOH pH 8.0, 200 mM NaCl, 5 mM dithiothreitole (DTT) at 4 °C. Cleaved proteins were 
concentrated using Amicon concentrators (Millipore) and further purified by SEC on a Superdex 200 
16/60 column using 20 mM HEPES/NaOH pH 8.0, 200 mM NaCl, 5 mM DTT as running buffer. 
Protein containing fractions were pooled and concentrated to 10 mg/mL. The protein complex was 
aliquoted, snap frozen and stored at -80 °C. 
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Mouse ARNT (residues 85-345), Δ274-301, C256S, cloned into pET 30EK-LIC (Novagen), was 
expressed as N-terminal Hexa-His-fusion proteins in BL21 Rosetta2(DE3) cells and purified as 
described above for the hetero-dimeric complex. 
DNA oligomer annealing: Equal concentrations (typically 800 µM) of DNA strand A and its 
complementary strand B were incubated at 90 °C for 5 min, followed by a slow cooling phase to room 
temperature over a time range of 6 h to allow for strand annealing. For simplicity, the sequence of only 
one strand is listed in this manuscript. 
RALS Analysis: A RALS-refractive index detector (Malvern) coupled to an analytical SEC column 
(Superdex 75 10/300) was used to determine absolute molecular masses of the applied samples. In each 
run, 100 µL of a 1.5 mg/mL protein solution was applied. Data were analyzed with the provided 
software OmniSec. The running buffer contained 20 mM HEPES pH 8.0, 200 mM NaCl, 5 mM DTT. 
For testing complex formation, a 12mer ds oligomer with the sequence 5‘-GGTTGCGTGACC-3‘ was 
used. For ARNT homo-dimerization experiments, an 18mer ds DNA with sequence 5’-
GCATAACACGTGTTATGC-3‘ was employed (presumed binding sites underlined). 
Isothermal titration calorimetry: ITC experiments were carried out at 20 °C in an ITC-200 device 
(GE Healthcare). dsDNA oligomers of various length (16mer: 5‘-AAGGTTGCGTGACCTT-3‘, 14mer: 
5‘-AGGTTGCGTGACCT-3‘, 12mer: 5‘-GGTTGCGTGACC-3‘, 10mer: 5‘-GTTGCGTGAC-3‘) in 20 
mM HEPES/NaOH pH 8.0, 200 mM NaCl, 5 mM DTT at a concentration of 400-550 µM was titrated 
into the reaction cell containing the AHR’:ARNT’ complex (30 µM). Binding isotherms were fitted 
and equilibrium dissociation constants calculated using the Microcal ORIGIN software. 
Crystallization and structure determination: For crystallization trials, the protein complex was 
incubated with a 1.2-fold molar excess of the 12mer dsDNA (12mer: 5‘-GGTTGCGTGACC-3‘) and 
purified by SEC using a Superdex 200 10/300 column. Fractions containing the AHR’:ARNT’-DNA 
complex were pooled, concentrated to 8.5 mg/mL and crystallized in a 24 well format by using the 
hanging drop vapor diffusion technique. 1 µl of the protein:DNA solution was mixed with 1.5 µL of 
the reservoir solution containing 10 mM HEPES/NaOH pH 6.8, 18% PEG3350, 200 mM ammonium 
formate. Plate-like crystals appeared after 5 days at 4 °C and reached their final size after 8 days (~ 0.4 
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mm x 0.1 mm x 0.025 mm). For crystal dehydration and derivatization with an anomalous scatterer, 
crystals were transferred for 1.5 h into a solution containing 35% PEG3350, 25 mM HEPES/NaOH pH 
8.0, 100 mM NaCl, 2 mM DTT, 230 mM ammonium formate and 5 mM Erbium-(III)-acetatedihydrate 
at 4 °C and afterwards directly flash cooled in liquid nitrogen. A full data set from a single crystal was 
recorded at beamline BL 14.1 at BESSY II, using a PILATUS 6M detector. Calculation of an optimal 
data collection strategy was done with the Mosflm software (Leslie, 2006). The SAD dataset was 
processed using the XDS program suite (Kabsch, 2010). The phase problem was solved by using the 
anomalous signal of 12 Er3+ atoms in the asymmetric unit using AutoSol (Terwilliger et al., 2009), 
which resulted in an unambiguous electron density map. Atomic model building was done by Coot 
(Emsley et al., 2010) and aided by the known bHLH domain of CLOCK-BMAL and the PAS-A domain 
of AHR. Iterative refinement was done using PHENIX (Adams et al., 2010) at a maximum resolution 
of 3.3 Å including the experimental phases and secondary structure restraints throughout refinement. 
TLS (translation, libration, screw axis rotation) refinement was done with one TLS group per domain 
or DNA oligomer. For the erbium atoms, anomalous B factors were refined. Chain A contains residues 
34-88, 109-250, 261-272, chain B residues 85-119, 126-143, 152-228, 259-269, 302-316, 324-329, 334-
345, chain C residues 32-88, 107-173, 211-227, 234-251, 255-271, chain D residues 84-144, 148-177, 
188-196, 199-203, 207-211, 259-269, 307-314, 337-342, chain E and G the DNA sequence 
GGTCACGCAACC, chain F and H the DNA sequence GGTTGCGTGACC. Figures were prepared 
using PyMOL Molecular Graphics System, Version 1.3 Schrödinger, LLC. Evaluation of atom contacts 
and geometry of the atomic model was done by the Molprobity server (Chen et al., 2010) and ccp4 
(Winn et al., 2011). Interface sizes were calculated with the PISA server (Krissinel et al., 2007). 
Plasmid mutagenesis: hsARNT and hsAHR were PCR amplified using Phusion polymerase (NEB) 
and cloned into pDONR201 using Gateway® cloning (Invitrogen) following the manufacturer’s 
instructions. Site directed mutagenesis was performed using primers (Table S2) designed with the 
NEBBaseChanger software (http://nebasechanger.neb.com/) and the Q5 SDM kit (NEB) following the 
manufacturer’s instructions. Mutagenized ARNT clones were shuttled into the Gateway® pDEST™26 
vector (Invitrogen) expressing N-terminally His tagged proteins, while AHR mutants were shuttled into 
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a C-terminally Halo tagged vector (gift of S. Pusch). Plasmid DNA was prepared for transfection using 
the Qiagen Plasmid Midi Kit. 
HEK cell transformation: HEK293T cells were transfected in 96 well plates with the indicated 
combination of AHR, ARNT and Cignal xenobiotic response element (XRE)-GFP reporter (Qiagen) 
plasmids using FuGENE®HD (Promega) following the manufacturer’s instructions 
(FuGENE®HD:DNA ratio 3:1). After 30 hours, the activity of the XRE-GFP reporter was measured 
using a Pherastar FS plate reader (BMG Labtech). Data represent the mean of three biological replicates 
normalized to the highest intensity result, where within each biological replicate each condition was 
repeated in triplicate. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Data fitting including baseline corrections, normalization, calculation of mean and error (SEM), and 
statistical tests were carried out in GraphPad Prism (version 5). The number of biological and technical 
replicates as well as the entity plotted are indicated in the figure legends. Data baseline correction and 
normalization, where applied, were indicated in the corresponding method section and in the axis labels. 
No explicit power analysis was used. 
 
DATA AND SOFTWARE AVAILABILITY 
Coordinates and structure factors of the AHR:ARNT complex bound to DNA have been deposited in 
the protein database (PDB) under accession code 5NJ8. 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Bacterial and Virus Strains  
E. coli strain BL21Rosetta2(DE3)  Novagen  
   
Chemicals, Peptides, and Recombinant Proteins 
Pefabloc SC Carl Roth  
DNAse I Carl Roth  
   
Critical Commercial Assays 
Q5 SDM kit NEB  
FuGENE®HD Promega  
   
Deposited Data 
Coordinates of DNA-bound AHR-ARNT PDB database 5NJ8 
   
Experimental Models: Cell Lines 
HEK293T ATCC  
   
Oligonucleotides 
Codon optimized cDNA of human AHR MWG Eurofins  
Primers Sigma see Table S1 
   
Recombinant DNA 
pET32-EK/LIC Novagen  
pET32-EK/LIC hsAHR (residues 23-273) This manuscript  
pET30-EK/LIC Novagen  
pET30-EK/LIC mmARNT (residues 85-345), 
Δ274-301, C256S 
This manuscript  
pDONR201 Invitrogen  
pDONR201-hsAHR This manuscript  
pDONR201-hsARNT This manuscript  
Gateway® pDEST™26 Invitrogen  
Gateway® pDEST™26 hsARNT This manuscript  
pHalo Gift S. Pusch  
pHalo hsAHR This manuscript  
Cignal XRE-GFP Qiagen  
   
Software and Algorithms 
Mosflm Leslie, 2006  
XDS Kabsch, 2010  
Autosol Terwilliger…., 2009  
Coot Emsely et al., 2010  
PHENIX Adams et al, 2010  
PyMOL Molecular Graphics System, 1.3 Schrödinger, LLC  
Molprobity Chen et al., 2010  
CCP4 Winn et al., 2011  
PISA server Krissinel et al., 2007  
NEBBaseChanger NEB http://nebasechanger.neb.com/ 
GraphPad Prism, version 5 GraphPad https://www.graphpad.com/ 
 
	
	
 
 
Figure S1: RALS analysis of ARNT’, related to Fig. 1. 
Chromatogram of the analytical gel filtration coupled to RALS of the ARNT protein in the absence and presence 
of a cognate 18mer dsDNA (sequence 5’-GCATAACACGTGTTATGC-3‘, ARNT binding site is underlined). 
UV absorbance is shown in dark blue/dark red and refers to the left y-axis, while the absolute molecular mass 
determined by RALS is shown in light blue/light red and refers to the right y-axis. The retention volume is 
plotted on the x-axis. 
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Figure S2: Content of the asymmetric unit, related to Fig. 2. 
A) Ribbon type representation of the two AHR/ARNT complexes bound to the 12mer dsDNA within the 
asymmetric unit. The DNA oligomers assembled into a continuous DNA double strand throughout the crystal. 
Domains of complex 1 are color coded as in Figure 2, complex 2 is colored in gray. The PAS domains of 
complex 2 are not stabilized by crystal contacts, resulting in disorder, a poor electron density and an incomplete 
model. B) Overlay of complex 1 and 2 of the asymmetric unit. The two complexes overlaid with a root mean 
square deviation of 1.2 Å.  
	
	
 
AHR    ---------- ---------- --MNSSSANI T--------- ---------- -YASRKRRKP VQKTVKPIPA  28    
AHRR   ---------- ---------M PRTMIPPGEC T--------- ---------- -YAGRKRRRP LQKQRPAVG-  30    
Hif1a  ---------- ---------- ---------- ---------- -------MEG AGGANDKKKI SSERR----K  19    
Hif2a  ---------- ---------- ---------- ---------- ---------- MTADKEKKRS SSERR----K  16    
Hif3a  ---------- ---------- ---------- ---------- ---------- MALGLQRARS TTELR----K  16    
NPAS1  ---------- ---------M AAPYPGSGGG SEVKCVGGRG ASVPWDFLPG LMVKAPSGPC LQAQR----K  47    
NPAS2  ---------- ---------- ---------- ---------- ---------- -MDEDEKDR- ----A----K  10    
NPAS3  MAPTKPSFQQ DPSRRERITA QHPLPNQSEC RKIYR----- -------YDG IY-CESTYQN LQALR----K  53    
NPAS4  ---------- ---------- ---------- ---------- ---------- ---------- ----M----Y  2     
SIM1   ---------- ---------- ---------- ---------- ---------- ---------- ----M----K  2     
SIM2   ---------- ---------- ---------- ---------- ---------- ---------- ----M----K  2     
CLOCK  ---------- ---------- ---MLFTVSC SKMSSIVDRD DS---SIFDG LVEEDDKDK- ----A----K  35    
 
 
 
AHR    EGIKSNPSKR HRDRLNTELD RLASLLPFPQ DVINKLDKLS VLRLSVSYLR AKSFFDVALK SSPTERNGGQ  98    
AHRR   -AEKSNPSKR HRDRLNAELD HLASLLPFPP DIISKLDKLS VLRLSVSYLR VKSFFQVVQE QSSRQPAAGA  99    
Hif1a  EKSRD-AARS RRSKESEVFY ELAHQLPLPH NVSSHLDKAS VMRLTISYLR VRKLLDAG-- -DL--DI---  80    
Hif2a  EKSRD-AARC RRSKETEVFY ELAHELPLPH SVSSHLDKAS IMRLAISFLR THKLLSSV-- -CSENES---  79    
Hif3a  EKSRD-AARS RRSQETEVLY QLAHTLPFAR GVSAHLDKAS IMRLTISYLR MHRLCAAG-- -EWN--Q---  77    
NPAS1  EKSRN-AARS RRGKENLEFF ELAKLLPLPG AISSQLDKAS IVRLSVTYLR LRRFAALG-A PPWGLRAAGP  115   
NPAS2  RASRNKSEKK RRDQFNVLIK ELSSMLPG-- -NTRKMDKTT VLEKVIGFLQ KHNEVSAQTE IC-DIQQ---  73    
NPAS3  EKSRD-AARS RRGKENFEFY ELAKLLPLPA AITSQLDKAS IIRLTISYLK MRDFANQG-D PPWNLRMEGP  121   
NPAS4  RSTKG-ASKA RRDQINAEIR NLKELLPLAE ADKVRLSYLH IMSLACIYTR KGVFFAGGT- P-----L---  62    
SIM1   EKSKN-AART RREKENSEFY ELAKLLPLPS AITSQLDKAS IIRLTTSYLK MRVVFPEGLG EAWGHSS---  68    
SIM2   EKSKN-AAKT RREKENGEFY ELAKLLPLPS AITSQLDKAS IIRLTTSYLK MRAVFPEGLG DAWGQPS---  68    
CLOCK  RVSRNKSEKK RRDQFNVLIK ELGSMLPG-- -NARKMDKST VLQKSIDFLR KHKEITAQSD AS-EIRQ---  98    
 
 
 
 
AHR    DN-------- -CRAANF--- -REGLNLQEG EFLLQALNGF VLVVTTALV  FYASSTIQDY LGFQQSDV--  153   
AHRR   PS-------- -PGDSCP--- -LAGSAVLEG RLLLESLNGF ALVVSAGTI  FYASATIVDY LGFHQTDV--  154   
Hif1a  ---------- ---------- -EDDMKAQMN CFYLKALDGF VMVLTDGDM  IYISDNVNKY MGLTQFEL--  127   
Hif2a  ---------- ---------- -EAEADQQMD NLYLKALEGF IAVVTQGDM  IFLSENISKF MGLTQVEL--  126   
Hif3a  ---------- ---------- -VGAGGEPLD ACYLKALEGF VMVLTAGDM  AYLSENVSKH LGLSQLEL--  124   
NPAS1  PAGLA----- -PGRRGPAAL VSEVFEQHLG GHILQSLDGF VFALNQGKF  LYISETVSIY LGLSQVEM--  177   
NPAS2  ---------- ---DWKPSFL ----SNEEFT QLMLEALDGF IIAVTTGSI  IYVSDSITPL LGHLPSDV--  124   
NPAS3  PPNTSVKVIG AQRRRSPSAL AIEVFEAHLG SHILQSLDGF VFALNQGKF  LYISETVSIY LGLSQVEL--  189   
NPAS4  ---------- ----AGP--- -TGLLSAQEL EDIVAALPGF LLVFTAGKL  LYLSESVSEH LGHSMVDLVA  114   
SIM1   ---------- ---RTSP--- -LDNVGRELG SHLLQTLDGF IFVVAPGKI  MYISETASVH LGLSQVEL--  119   
SIM2   ---------- ---RAGP--- -LDGVAKELG SHLLQTLDGF VFVVASGKI  MYISETASVH LGLSQVEL--  119   
CLOCK  ---------- ---DWKPTFL ----SNEEFT QLMLEALDGF FLAIMTGSI  IYVSESVTSL LEHLPSDL--  149   
 
 
 
 
AHR    IHQSVYELIH TEDRAEFQRQ LHWALNPSQC TESGQGIE-- ---EATG--- --LPQTVVCY NPDQIPPENS  213   
AHRR   MHQNIYDYIH VDDRQDFCRQ LHWAMDPPQV VFGQPPPLET GDDAILG--- --RLLRAQ-E WGTGTPTEYS  218   
Hif1a  TGHSVFDFTH PCDHEEMREM LTHRN--GL- ---------- ---------- ---------- --VK--KGKE  160   
Hif2a  TGHSIFDFTH PCDHEEIREN LSLKNGSGF- ---------- ---------- ---------- --GK--KSKD  161   
Hif3a  IGHSIFDFIH PCDQEELQDA LTPQQ--TL- ---------- ---------- ---------- --SR--RKVE  157   
NPAS1  TGSSVFDYIH PGDHSEVLEQ LGLRTPTPGP PTP-PSVSS- --SSSSSSSL ADTPE-IEAS LTKV--PPSS  240   
NPAS2  MDQNLLNFLP EQEHSEVYKI LSSHMLVTDS P--------- ---------- --SP------ --EY--LKS-  162   
NPAS3  TGSSVFDYVH PGDHVEMAEQ LGMKLPPGRG LLS-QGTAED GASSASSSSQ SETPEPVEST SPSL--LTTD  256   
NPAS4  QGDSIYDIID PADHLTVRQQ LTLPSAL--- ---------- ---------- ---------- ----------  141   
SIM1   TGNSIYEYIH PADHDEMTAV LTAHQPYH-- ---------- ---------- ---------- --SH--FVQE  153   
SIM2   TGNSIYEYIH PSDHDEMTAV LTAHQPLH-- ---------- ---------- ---------- --HH--LLQE  153   
CLOCK  VDQSIFNFIP EGEHSEVYKI LSTHLLESDS L--------- ---------- --TP------ --EY--LKS-  
α1 α2 
A’α Aß Bβ Cα Dα 
Eα Fα 
	
	
 
Figure S3: Sequence alignment of human class I bHLH-PAS domain transcription factors, related to Fig. 
3 and 4. 
bHLH and PAS A domains of the following human sequences were aligned with ClustalW (Larkin et al., 2007): 
AHR (expasy accession code P35869), AHR repressor (A9YTQ3), Hif-1 (Q16665), HIF-2 (Q99814), HIF3 
(Q9Y2N7), NPAS1 (Q99742), NPAS2 (Q99743), NPAS3 (Q8IXF0), NPAS4 (Q8IUM7), SIM1 (P81133), SIM2 
(Q14190), CLOCK (O15516). The secondary structure as observed in the AHR’-ARNT’complex is indicated 
on top. Residues with a type conservation of greater than 80% are color-coded (D,E in red; R,K,H in blue; 
N,Q,S,T in grey; L, I, V, F, Y, W, M, C in green, A,G,P in yellow). Interface residues, as observed in our 
structure, are marked with a square. Residues which have previously been shown to be crucial for dimerization 
(Wu et al., 2013; Wu et al., 2015; Wu et al., 2016) are indicated with a circle. The HIF-2 loop shown to be 
involved in DNA binding is boxed.  
  
 
 
 
AHR    PLMERCFICR LRCLLDN--- -----SSGFL AMNFQGKLKY LHGQKKKGK- ---------D GSILPPQLAL  265   
AHRR   AFLTRCFICR VRCLLDS--- -----TSGFL TMQFQGKLKF LFGQKKKAP- ---------S GAMLPPRLSL  270   
Hif1a  QNTQRSFFLR MKCTLTSRGR TMNIKSATWK VLHCTGHIHV YDTN-SNQPQ ---CGYK--- ---KPPMTCL  220   
Hif2a  MSTERDFFMR MKCTVTNRGR TVNLKSATWK VLHCTGQVKV YNNCPPHNSL ---CGYK--- ---EPLLSCL  222   
Hif3a  APTERCFSLR MKSTLTSRGR TLNLKAATWK VLNCSGHMRA YKPPAQTSPA --GSPDS--- ---EPPLQCL  219   
NPAS1  LVQERSFFVR MKSTLTKRG- -LHVKASGYK VIHVTGRLRA ---------- ---------- -----HALGL  283   
NPAS2  -DSDLEFYCH L-----LRGS LNPKEFPTYE YIKFVGNFRS YNNVPSPSCN GFDNTLSRPC RVPLGKEVCF  226   
NPAS3  NTLERSFFIR MKSTLTKRG- -VHIKSSGYK VIHITGRLRL RVSLSHGR-- --TVPS---- -----QIMGL  311   
NPAS4  -DTDRLFRCR FNTSK----- SLRRQSAGNK LVLIRGRFHA HPPGAYW--- -----AG--- ---NP---VF  188   
SIM1   YEIERSFFLR MKCVLAKRN- -AGLTCGGYK VIHCSGYLKI RQYSLDMSPF --DGCY---- -----QNVGL  210   
SIM2   YEIERSFFLR MKCVLAKRN- -AGLTCSGYK VIHCSGYLKI RQYMLDMSLY --DSCY---- -----QIVGL  210   
CLOCK  -KNQLEFCCH M-----LRGT IDPKEPSTYE YVKFIGNFKS LNSVSSSAHN GFEGTIQRTH RPSYEDRVCF  251   
 
 
 
 
 
 
AHR    FAIATPL--- ----QPPSIL EIRTKNFIFR TKHKLDFTPI GCDAKGRIVL GYTEAELCTR GSGYQFIHAA  328   
AHRR   FCIAAPV--- ----LLPSAA EMKMRSALLR AKPRADTAAT A-DAKVKATT SLCESELHGK ----------  322   
Hif1a  VLICEPI--- ----PHPSNI EIPLDSKTFL SRHSLDMKFS YCDERITELM GYEPEELLGR -SIYEYYHAL  282   
Hif2a  IIMCEPI--- ----QHPSHM DIPLDSKTFL SRHSMDMKFT YCDDRITELI GYHPEELLGR -SAYEFYHAL  284   
Hif3a  VLICEAI--- ----PHPGSL EPPLGRGAFL SRHSLDMKFT YCDDRIAEVA GYSPDDLIGC -SAYEYIHAL  281   
NPAS1  VALGHTL--- ----PPAPLA ELPLHGHMIV FRLSLGLTIL ACESRVSDHM DLGPSELVGR -SCYQFVHGQ  345   
NPAS2  IATVRLATPQ ----FLKEMC IVDEPLEEFT SRHSLEWKFL FLDHRAPPII GYLPFEVLGT -SGYDYYHID  291   
NPAS3  VVVAHAL--- ----PPPTIN EVRIDCHMFV TRVNMDLNII YCENRISDYM DLTPVDIVGK -RCYHFIHAE  373   
NPAS4  TAFCAPLEPR PRPGPGPGPG PASLFLAMFQ SRHAKDLALL DISESVLIYL GFERSELLCK -SWYGLLHPE  257   
SIM1   VAVGHSL--- ----PPSAVT EIKLHSNMFM FRASLDMKLI FLDSRVAELT GYEPQDLIEK -TLYHHVHGC  272   
SIM2   VAVGQSL--- ----PPSAIT EIKLYSNMFM FRASLDLKLI FLDSRVTEVT GYEPQDLIEK -TLYHHVHGC  272   
CLOCK  VATVRLATPQ ----FIKEMC TVEEPNEEFT SRHSLEWKFL FLDHRAPPII GYLPFEVLGT -SGYDYYHVD  316   
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Figure S4: Sequence alignment of human class II bHLH-PAS domain transcription factors, related to Fig. 
3 and 4. 
bHLH and PAS A domains of the following human sequences were aligned with ClustalW: ARNT (expasy 
accession code P27540), ARNT2 (Q9HBZ2), BMAL1 (O00327) and BMAL2 (Q8WYA1). The secondary 
structure as observed in the AHR’-ARNT’complex is indicated on top. Residues with a type conservation of 
100% are color-coded (D,E in red; R,K,H in blue; N,Q,S,T in grey; L, I, V, F, Y, W, M, C in green, A,G,P in 
yellow). Interface residues, as observed in our structure, are marked with a square. Residues which have 
previously been shown to be crucial for dimerization (Wu et al., 2013; Wu et al., 2015; Wu et al., 2016) are 
indicated with a circle.   
ARNT   ---------- ----MAATTA NPEMTSDVPS LGPA-IASGN SGPGIQGGGA IVQRAIKRRP GLDFDDD-G-  53  
ARNT2  ---------- --MATPAAVN PPEMASDIPG SVTLPVAPMA ATGQVRMAGA MPARGGKRRS GMDFDDEDG-  57  
BMAL1  ---------- ---MADQRMD ISSTISDFMS PGPTDLLSSS LGT------- SGVDCNRKRK GSSTDYQES-  49  
BMAL2  MAAEEEAAAG GKVLREENQC IAPVVSSRVS PGTRPTAMGS FSS------- HMTEFPRKRK GSDSDPSQSG  63  
 
ARNT   EGN------- ----SKFLRC DDDQMSNDKE RFARSDDEQS SADKERLARE NHSEIERRRR NKMTAYITEL  112 
ARNT2  EG-------- ---------- ---------- ---------- ---PSKFSRE NHSEIERRRR NKMTQYITEL  86  
BMAL1  ---------- ---------- MDT-DKDDP- -HGR-LEYTE HQGRIKNARE AHSQIEKRRR DKMNSFIDEL  95  
BMAL2  IMTEKVVEKL SQNPLTYLLS TRIEISASS- -GSR-VEDGE HQVKMKAFRE AHSQTEKRRR DKMNNLIEEL  130 
 
 
 
 
                       ARNT   SDMVPTCSAL ARKPDKLTIL RMAVSHMKSL RGTGNTSTDG SYKPSFLTDQ ELKHLILEAA DGFLFIVSCE  182 
ARNT2  SDMVPTCSAL ARKPDKLTIL RMAVSHMKSM RGTGNKSTDG AYKPSFLTEQ ELKHLILEAA DGFLFVVAAE  156 
BMAL1  ASLVPTCNAM SRKLDKLTVL RMAVQHMKTL RGATNPYTEA NYKPTFLSDD ELKHLILRAA DGFLFVVGCD  165 
BMAL2  SAMIPQCNPM ARKLDKLTVL RMAVQHLRSL KGLTNSYVGS NYRPSFLQDN ELRHLILKTA EGFLFVVGCE  200 
 
              
 
 
 
ARNT   TGRVVYVSDS VTPVLNQPQS EWFGSTLYDQ VHPDDVDKLR EQLSTSENAL TGRILDLKTG TVKK-EGQQS  251 
ARNT2  TGRVIYVSDS VTPVLNQPQS EWFGSTLYEQ VHPDDVEKLR EQLCTSENSM TGRILDLKTG TVKK-EGQQS  225 
BMAL1  RGKILFVSES VFKILNYSQN DLIGQSLFDY LHPKDIAKVK EQLSSSDTAP RERLIDAKTG LPVKTDITPG  235 
BMAL2  RGKILFVSKS VSKILNYDQA SLTGQSLFDF LHPKDVAKVK EQLSSFDISP REKLIDAKTG LQVHSNLHAG  270 
ARNT   SMRMCMGSRR SFICRMRCGS SSVDPVSVNR LSFVRNRCRN GLGSVKDGEP HFVVVHCTGY IKAWPPAGVS  321 
ARNT2  SMRMCMGSRR SFICRMRCGN APLDHLPLNR ITTMRKRFRN GLGPVKEGEA QYAVVHCTGY IKAWPPAGMT  295 
BMAL1  PSRLCSGARR SFFCRMKCNR PSVKVED--- -----KDFPS TCSKKKADRK SFCTIHSTGY LKSWPPTKMG  297 
BMAL2  RTRVYSGSRR SFFCRIKSCK ISVKEEH--- -----GCLPN S---KKKEHR KFYTIHCTGY LRSWPPNIVG  329 
ARNT   LPDDDPEAGQ GS-KFCLVAI GRLQVTSSPN CTDMSNVCQP TEFISRHNIE GIFTFVDHRC VATVGYQPQE  390 
ARNT2  IPEEDADVGQ GS-KYCLVAI GRLQVTSSPV CMDMNGMSVP TEFLSRHNSD GIITFVDPRC ISVIGYQPQD  364 
BMAL1  LDEDNEPDNE GCNLSCLVAI GRLHSHVVPQ PVNGEIRVKS MEYVSRHAID GKFVFVDQRA TAILAYLPQE  367 
BMAL2  MEEERNSKKD NSNFTCLVAI GRLQPYIVPQ N-SGEINVKP TEFITRFAVN GKFVYVDQRA TAILGYLPQE  398 
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Table S1: Primers used for site directed mutagenesis, related to Fig. 3. 
hsAHR R40D SDM F Tm58  CAAGCGGCATgatGACCGACTTAATAC 
hsAHR R40D SDM R Tm58  GAAGGATTTGACTTGATTCC 
hsAHR L50D SDM F Tm59  GTTGGACCGTgatGCTAGCCTGC 
hsAHR L50D SDM R Tm59  TCTGTATTAAGTCGGTCTC 
hsAHR V74D SDM F Tm61  TAGGCTCAGCgatAGTTACCTGAG 
hsAHR V74D SDM R Tm61  AGAACTGAAAGTTTGTCCAAC 
hsAHR A79D SDM F Tm62  TTACCTGAGAgatAAGAGCTTCTTTGATG 
hsAHR F79D SDM R Tm61  CTGACGCTGAGCCTAAGAAC 
hsAHR F81D SDM F Tm61  AGCCAAGAGCgatTTTGATGTTGCATTAAAATC 
hsAHR A81D SDM R Tm62  CTCAGGTAACTGACGCTG 
hsAHR F136D SDM F Tm59  TGCTTTGGTCgatTATGCTTCTTCTAC 
hsAHR F136D SDM R Tm59  TCTGTAGTGACAACTAATACAAAG 
hsAHR I154D SDM F Tm59  GTCTGATGTCgatCATCAGAGTGTATATGAACTTATC 
hsAHR I154D SDM R Tm59  TGCTGAAACCCTAGATAATC 
hsAHR Δ288‐421 SDM F Tm59  gCCATAATGGATCCCTTACC 
hsAHR Δ288‐421 SDM R Tm59  tCTAAAGATAAAATTTTTGGTCCG 
hsAHR R102D SDM F Tm58  ACGGCGGCGAgatAACAAGATGAC 
hsAHR R102D SDM R Tm58  TCAATTTCACTGTGATTTTCC 
hsAHR L112D SDM F Tm59  CATCACAGAAgatTCAGATATGGTACCCACCTG 
hsAHR L112D SDM R Tm59  TAGGCTGTCATCTTGTTC 
hsAHR M139D SDM F Tm61  AGTTTCTCACgatAAGTCCTTGCGGGGAAC 
hsAHR M139D SDM R Tm61  GCCATGCGTAAGATGGTTAG 
hsAHR L164D SDM F Tm59  TGATCAGGAAgatAAACATTTGATCTTGGAGG 
hsAHR L164D SDM R Tm59  GTGAGGAAAGACGGCTTATAG 
 
